Reducing Pantoprazole Dosage for Maintenance Therapy

Introduction to Dose Reduction

• The American Gastroenterological Association recommends that patients without a definitive indication for chronic PPI should be considered for de-prescribing or dose reduction 1
• Most patients on twice-daily dosing should be considered for step down to once-daily PPI, as stated by the American Gastroenterological Association 1

Dosing Considerations

• Low-dose PPI therapy (≤40mg pantoprazole daily) is recommended over high-dose therapy for long-term management, according to the American College of Gastroenterology 2

Treatment of Specific Conditions

• Patients with complicated GERD (severe erosive esophagitis, esophageal ulcer, peptic stricture) should generally not be considered for PPI discontinuation or dose reduction, as per the American Gastroenterological Association guidelines 1
• For treatment of Helicobacter pylori infection, the standard 40mg dose is recommended as part of combination therapy, according to the American College of Gastroenterology 3, 4

Relative Potency and Implementation

• Pantoprazole has lower relative potency compared to other PPIs (40mg pantoprazole = 9mg omeprazole; 20mg esomeprazole = 32mg omeprazole), as noted by the American College of Gastroenterology 3, 4
• When reducing dose, monitor for return of symptoms, which would indicate need to return to higher dose, as recommended by the American Gastroenterological Association 1

Potential Benefits

• Lower medication costs and reduced pill burden can be achieved with dose reduction, according to the American Gastroenterological Association 1
• Potentially reduced risk of long-term adverse effects associated with PPI use can be achieved with dose reduction, as stated by the American Gastroenterological Association 1